Safety and Pharmacokinetics Study of FBF001

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

The purpose of this study is to assess the clinical and laboratory safety and to determine the pharmacokinetic profile of FBF001.

Phase 1

Fab'entech